Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,850 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Peritoneal Metastases in a Patient-derived Orthotopic Xenograft (PDOX) Model of Colon Cancer Imaged Non-invasively via Red Fluorescent Protein Labeled Stromal Cells.
Park JH, Zhao M, Oshiro H, Miyake K, Higuchi T, Reynoso J, Razmjooei S, Bouvet M, Clary B, Zhang Z, Sugisawa N, Yamamoto J, Singh SR, Hoffman RM. Park JH, et al. Among authors: yamamoto j. Anticancer Res. 2019 Jul;39(7):3463-3467. doi: 10.21873/anticanres.13492. Anticancer Res. 2019. PMID: 31262870
Efficacy of oral recombinant methioninase combined with oxaliplatinum and 5-fluorouracil on primary colon cancer in a patient-derived orthotopic xenograft mouse model.
Park JH, Zhao M, Han Q, Sun Y, Higuchi T, Sugisawa N, Yamamoto J, Singh SR, Clary B, Bouvet M, Hoffman RM. Park JH, et al. Among authors: yamamoto j. Biochem Biophys Res Commun. 2019 Oct 15;518(2):306-310. doi: 10.1016/j.bbrc.2019.08.051. Epub 2019 Aug 14. Biochem Biophys Res Commun. 2019. PMID: 31421825
The combination of oral-recombinant methioninase and azacitidine arrests a chemotherapy-resistant osteosarcoma patient-derived orthotopic xenograft mouse model.
Higuchi T, Sugisawa N, Yamamoto J, Oshiro H, Han Q, Yamamoto N, Hayashi K, Kimura H, Miwa S, Igarashi K, Tan Y, Kuchipudi S, Bouvet M, Singh SR, Tsuchiya H, Hoffman RM. Higuchi T, et al. Among authors: yamamoto j, yamamoto n. Cancer Chemother Pharmacol. 2020 Feb;85(2):285-291. doi: 10.1007/s00280-019-03986-0. Epub 2019 Nov 8. Cancer Chemother Pharmacol. 2020. PMID: 31705268
Oral recombinant methioninase combined with oxaliplatinum and 5-fluorouracil regressed a colon cancer growing on the peritoneal surface in a patient-derived orthotopic xenograft mouse model.
Park JH, Han Q, Zhao M, Tan Y, Higuchi T, Yoon SN, Sugisawa N, Yamamoto J, Bouvet M, Clary B, Singh SR, Hoffman RM. Park JH, et al. Among authors: yamamoto j. Tissue Cell. 2019 Dec;61:109-114. doi: 10.1016/j.tice.2019.09.006. Epub 2019 Sep 21. Tissue Cell. 2019. PMID: 31759402
PPARγ Agonist Pioglitazone in Combination With Cisplatinum Arrests a Chemotherapy-resistant Osteosarcoma PDOX Model.
Higuchi T, Yamamoto J, Sugisawa N, Tashiro Y, Nishino H, Yamamoto N, Hayashi K, Kimura H, Miwa S, Igarashi K, Bouvet M, Singh SR, Tsuchiya H, Hoffman RM. Higuchi T, et al. Among authors: yamamoto j, yamamoto n. Cancer Genomics Proteomics. 2020 Jan-Feb;17(1):35-40. doi: 10.21873/cgp.20165. Cancer Genomics Proteomics. 2020. PMID: 31882549 Free PMC article.
Oral Recombinant Methioninase Prevents Obesity in Mice on a High-fat Diet.
Tashiro Y, Han Q, Tan Y, Sugisawa N, Yamamoto J, Nishino H, Inubushi S, Higuchi T, Aoki T, Murakami M, Hoffman RM. Tashiro Y, et al. Among authors: yamamoto j. In Vivo. 2020 Mar-Apr;34(2):489-494. doi: 10.21873/invivo.11799. In Vivo. 2020. PMID: 32111745 Free PMC article.
Oral Recombinant Methioninase Inhibits Diabetes Onset in Mice on a High-fat Diet.
Tashiro Y, Han Q, Tan Y, Sugisawa N, Yamamoto J, Nishino H, Inubushi S, Sun YU, Zhu G, Lim H, Aoki T, Murakami M, Bouvet M, Hoffman RM. Tashiro Y, et al. Among authors: yamamoto j. In Vivo. 2020 May-Jun;34(3):973-978. doi: 10.21873/invivo.11865. In Vivo. 2020. PMID: 32354882 Free PMC article.
Eribulin Regresses a Cisplatinum-resistant Rare-type Triple-negative Matrix-producing Breast Carcinoma Patient-derived Orthotopic Xenograft Mouse Model.
Yamamoto J, Murata T, Sugisawa N, Higuchi T, Tashiro Y, Nishino H, Inubushi S, Sun YU, Lim H, Miyake K, Shimoya K, Nomura T, Kurebayashi J, Tanino H, Hozumi C, Bouvet M, Singh SR, Endo I, Hoffman RM. Yamamoto J, et al. Anticancer Res. 2020 May;40(5):2475-2479. doi: 10.21873/anticanres.14217. Anticancer Res. 2020. PMID: 32366391
1,850 results